Events

ASCO 2018 - QIAGEN CEO Peer Schatz about the...

Interview with Peer Schatz, CEO of QIAGEN, about the importance of the ASCO annual meeting and...

ECCMID 2018 - Official QIAstat-Dx launch, the...

Introducing the next generation of syndromic insights. The launch of QIAstat-Dx at ECCMID 2018....

Ugo Sottotetti from DiaSorin speaks at ESCV...

Ugo Sottotetti, Senior Marketing Manager at DiaSorin, speaks about latent Tuberculosis testing....

Impressions from ESCV 2018 in Athens

Announcing the partnership with NeuMoDx, launching the N288 and N96, showcasing the QIAstat-Dx...

Launch of the NeuMoDx System at ESCV in Athens...

The NeuMoDx N96 and N288 systems were formally launched at the QIAGEN booth at ESCV 2018 in...

NeuMoDx President & COO Sundu Brahmasandra...

At ESCV in Athens, Greece, following the official launch of the NeuMoDx platform, President COO...

ASCO 2018 - Thierry Bernard discusses the...

Thierry Bernard, Senior Vice President Molecular Diagnostics, QIAGEN discusses the reception of...

ASCO 2018 - Dr. Vincent Funari on the...

Interview with Dr. Vincent Funari, Technical Director, NeoGenomics Molecular Laboratory. Dr....

ASCO 2018 - Tip of the Day (Monday)

Tip of the Day for Monday, June 4th by Jonathan Arnold, Vice President, Head of Partnering for...

ASCO 2018 - Timothy B Johnson on partnering...

Interview with TJ Johnson, CEO of HTG Molecular, on the development of new oncology offerings...

ASCO 2018 - Analyst Puneet Souda on the impact...

Leerink Analyst Puneet Souda comments at ASCO on the impact of Next Generation Sequencing and...